Indium (111In) imciromab
Source: Wikipedia, the free encyclopedia.
Fab fragment | |
---|---|
Source | Mouse |
Target | cardiac myosin |
Clinical data | |
Trade names | Myoscint |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
|
ChemSpider |
|
UNII | |
NY (what is this?) (verify) |
Indium (111In) imciromab (trade name Myoscint) is a
cardiac imaging, but withdrawn in 1993.[2]
See also
References
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | |||||||||
---|---|---|---|---|---|---|---|---|---|
Bone |
| ||||||||
Musculoskeletal |
| ||||||||
Circulatory |
| ||||||||
Neurologic |
| ||||||||
Angiogenesis inhibitor |
| ||||||||
Growth factor |
| ||||||||
|
This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
This nuclear medicine article is a stub. You can help Wikipedia by expanding it. |